Mathew Aby J. sold BLFS

October 9, 2025 · Form 4 insider transaction

Mathew Aby J. sold 509 shares of BioLife Solutions, Inc. at $27.36 per share, a transaction worth $13.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Disposed (sell-side)
Shares
509
Price
$27.36
Total value
$13.9K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 9, 2025
Filing dateOctober 14, 2025
Shares owned after350,912
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

View the original Form 4 on SEC EDGAR